Complicated Osteoporosis in Progeroid Syndrome: Treatment With Teriparatide

被引:0
|
作者
Iglesias Bolanos, Paloma [1 ]
Guijarro de Armas, Guadalupe [1 ]
Civantos Modino, Soraya [1 ]
Vega Pinero, Belen [1 ]
Pavon de Paz, Isabel [1 ]
Monereo Megias, Susana [1 ]
机构
[1] Getafe Univ Hosp, Dept Endocrinol, Madrid 28007, Spain
关键词
Fracture; osteoporosis; progeroid syndrome; teriparatide; MODEL;
D O I
10.1016/j.jocd.2011.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human progeroid syndromes (PSs) include a group of genetic "premature aging" diseases that affect a variety of organ systems. Bone diseases are common sequelae of patients diagnosed with PSs. Teriparatide therapy is recommended for elderly men with low bone mineral density (BMD; T-score < -2.5) and at least 1 fragility fracture who are unable to tolerate bisphosphonates. We describe a 20-yr-old patient affected by PS and severe osteoporosis complicated with femoral fracture. The patient experienced a significant improvement in lumbar spine BMD after treatment with teriparatide.
引用
收藏
页码:116 / 119
页数:4
相关论文
共 50 条
  • [41] Contributors to Secondary Osteoporosis in Patients Referred for Treatment with Teriparatide
    Anaforoglu, Inan
    Asik, Mehmet
    Ersoy, Kerem
    Kose, Mustafa
    Ayhan, Semiha
    Algun, Ekrem
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 17 (04) : 98 - 101
  • [42] Clinical experience with teriparatide (TPDT) in the treatment of severe osteoporosis
    Finkenstedt, G.
    Finkenstedt, A.
    Gasser, R. W.
    Götsch, C.
    BONE, 2006, 39 (05) : S39 - S40
  • [43] Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men
    R. Niimi
    T. Kono
    A. Nishihara
    M. Hasegawa
    A. Matsumine
    T. Kono
    A. Sudo
    Osteoporosis International, 2015, 26 : 2221 - 2221
  • [44] Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants
    Begin, Marie-Josee
    Ste-Marie, Louis-Georges
    Coupal, Louis
    Ethier, Jean
    Rakel, Agnes
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (08) : 1444 - 1449
  • [45] Teriparatide for severe osteoporosis
    Cappuzzo, KA
    Delafuente, JC
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 294 - 302
  • [46] Spotlight on Teriparatide in Osteoporosis
    Stephanie K.A. Blick
    Sohita Dhillon
    Susan J. Keam
    BioDrugs, 2009, 23 : 197 - 199
  • [47] Teriparatide, HRT and osteoporosis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S127 - S127
  • [48] Teriparatide (Forteo) for osteoporosis
    Bazaldua, OV
    Bruder, J
    AMERICAN FAMILY PHYSICIAN, 2004, 69 (08) : 1983 - 1984
  • [49] Teriparatide in the management of osteoporosis
    Bodenner, Donald
    Redman, Carolyn
    Riggs, Ann
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (04) : 499 - 507
  • [50] Spotlight on Teriparatide in Osteoporosis
    Blick, Stephanie K. A.
    Dhillon, Sohita
    Keam, Susan J.
    BIODRUGS, 2009, 23 (03) : 197 - 199